EFM
HUMA icon

E Fund Management’s Humacyte HUMA Stock Holding History

E Fund Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$43.1K Buy
20,625
+3,492
+20% +$6.71K ﹤0.01% 392
2025
Q1 		$29.2K Buy
17,133
+788
+5% +$2.96K ﹤0.01% 397
2024
Q4 		$82.5K Buy
16,345
+476
+3% +$2.35K ﹤0.01% 382
2024
Q3 		$86.3K Buy
+15,869
New +$105K ﹤0.01% 342

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

E Fund Management's HUMA Position: Q2 2025 in Review

E Fund Management increased its Humacyte (HUMA) stake by 20% in Q2 2025, buying an estimated $6.71K and bringing the position to 20,625 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #392.

E Fund Management first reported a position in HUMA in Q3 2024 and has held it in 4 quarters since. The position peaked at $86.3K in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • E Fund Management held 20,625 shares of Humacyte worth $43.1K as of Q2 2025.
  • E Fund Management bought 3,492 Humacyte shares in Q2 2025, an estimated $6.71K.
  • Humacyte made up ﹤0.01% of E Fund Management's portfolio in Q2 2025, its #392 holding.
  • E Fund Management first reported a position in Humacyte in Q3 2024 and has held it in 4 quarters since.
  • E Fund Management's Humacyte position peaked at $86.3K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.